About the Project
We have developed (and patented) a new, cheaper and more effective PAP-based vaccine for the treatment of advanced prostate cancer which consists of a mutated 42mer PAP-derived peptide. The project will build upon the data generated to date by demonstrating the ability of vaccine-induced T-cells to slow-down/inhibit the growth of human prostate cancer cells and tumours expressing PAP. It will also assess whether CD4+ T-cells can be induced if a plasmid DNA coding for the entire PAP is first used, followed by administration of the mutated PAP 42mer vaccine.
The project requires a highly motivated and dedicated student with the ability to deliver science of the highest quality and ambition to progress this new therapeutic towards a First in Man clinical trial.
Applicants should hold, or be expected to hold, an UK Master’s degree (or UK equivalent according to NARIC) with a minimum of a commendation, and/or a UK 1stClass / 2.1 Bachelor’s Honour’s Degree (or UK equivalent according to NARIC) in Cell Biology, Biochemistry, Molecular Biology, or a related Biosciences related subject.
English Language Requirements for all research degree programmes:
You will need an overall IELTS (International English Language Testing System) score of 6.5 with minimum sub-scores of 6.0 in all component sections (writing, reading, listening and speaking). We’ll normally ask applicants who do not meet the English language proficiency requirement to successfully complete an English language course at Nottingham Language Centre.
Based on your current searches we recommend the following search filters.
Based on your current search criteria we thought you might be interested in these.